Skip to main content
Erschienen in: BMC Public Health 1/2024

Open Access 01.12.2024 | Research

The best internal structure of the Diabetes Quality of Life Measure (DQOL) in Brazilian patients

verfasst von: Denilson Menezes Almeida, Aldair Darlan Santos-de-Araújo, José Mário Costa Brito Júnior, Marcela Cacere, André Pontes-Silva, Cyrene Piazera Costa, Maria Cláudia Gonçalves, José Márcio Soares Leite, Almir Vieira Dibai-Filho, Daniela Bassi-Dibai

Erschienen in: BMC Public Health | Ausgabe 1/2024

Abstract

Background

Diabetes Mellitus (DM) is considered a chronic disease with numerous secondary complications that negatively affect the quality of life of patients. However, the specific, known and validated instruments for Brazilian Portuguese are too extensive, which often makes their use infeasible.

Objective

To validate the internal structure of the Brazilian version of the Diabetes Quality of Life (DQOL) measure.

Methodology

Patients with DM type 1 or 2, between the ages of 18 and 76, were evaluated between April 2022 and May 2022. The survey was conducted online using the Google Forms platform. The original DQOL contains 46 multiple-choice questions organized into four domains. For structural validity, confirmatory factor analysis (CFA) was performed using RStudio software (Boston, MA, USA) with the packages lavaan and semPlot.

Results

A total of 354 subjects were evaluated. The 3-domain, 24-item version of the DQOL was the most adequate, with acceptable values for all fit indices (chi-square/GL < 3, TLI and CFI > 0.90, and RMSEA and SRMR < 0.08).

Conclusion

The structure with three domains and 24 items is the most appropriate based on factor analysis. The Brazilian version of the DQOL with a structure of 3 domains and 24 items has adequate measurement properties that support its use in the clinical and scientific context in patients with DM.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Science has made significant advances each year in the identification, screening and targeting of more effective therapies in the prevention of adverse outcomes and the efficient glycemic control of diabetic patients; however, considering the multisystemic influence of the disease, aspects such as activities of daily living, occupation and social relationships are often affected due to organ system complications and impaired quality of life, even leading to non-adherence to treatment [1, 2]. Neglected for many years due to the therapeutic model of treatment of the pathology focused primarily on glycemic control, the quality of life of this population has been the object of interest in several studies and numerous factors have been identified capable of contributing to the worsening of this outcome, such as the presence of the pathology itself, psychosocial aspects, associated comorbidities, type of disease and even demographic and socioeconomic aspects [3, 4].
Several instruments with different orientations and approaches have been developed to assess the quality of life in this population; however, the choice of an adequate and accurate instrument to assess the proposed outcomes can generate difficulties in selecting the best instrument, since to be considered adequate, its measurement properties must have been thoroughly studied and proven to avoid bias [5, 6].
In this context, the Diabetes Quality of Life Measure (DQOL) has become a valid and widely used instrument to assess the quality of life of patients with type 1 and type 2 diabetes mellitus (DM), due to its content validity by experts, good reliability and adequate internal consistency [7]. The Brazilian version of this instrument is originally composed of 44 questions [8], however, although this Brazilian version showed good internal consistency, good discriminant validity (detection of a difference in the perception of quality of life between patients with HbA1c above and below 9%), good correlation between the scores obtained in each domain and convergent validity, its internal structure was not properly evaluated, since the authors did not perform factor analysis.
Thus, a measurement property to be verified in the Brazilian version of the DQOL is the structural validity, in order to determine the degree to which the internal structure of this instrument is adequate for the construct to be measured [8, 9]. Aware of this gap, the discriminatory capacity of the questionnaire, the importance and its wide use in clinical and scientific contexts, in addition to its potential contribution in therapeutic decision-making, this questionnaire was not subjected to a rigorous factor analysis, raising the hypothesis of the possibility that this instrument has adequate internal structural validity in what it proposes to investigate. Parallel to this hypothesis, this study aims to identify the best internal structure of the Brazilian version of the DQOL.

Methodology

Study design and ethical aspects

An observational study to assess the psychometric properties of the DQOL, conducted according to the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) [9]. This study was conducted through face-to-face collection in health units in São Luís (Maranhão, Northeastern Brazil) and through the online platform Google Forms (Mountain View, CA, USA). The study procedures were approved by the Research Ethics Committee of the Universidade Ceuma (process number 2.853.570) and conducted according to the Declaration of Helsinki. All subjects were informed of the purpose and procedures of the study, and informed consent was obtained prior to participation.

Sample size and participants

Recruitment of the volunteers took place through verbal contact, posters and social media. All volunteers included in the study validated their participation by signing or electronically consenting on the free and informed consent form. The sample size was defined as 7 patients for each item on the scale [10]. Considering the DQOL has 46 items, the appropriate minimum number established was 322 patients.
The inclusion criteria were: patients aged 18 years or over, both sexes, clinically diagnosed with type 1 or 2 diabetes mellitus. While the exclusion criteria were: those who had any conditions that prevented them from answering the proposed questionnaire.

Diabetes quality of life measure (DQOL)

The original Brazilian version of the DQOL contains 44 multiple-choice questions organized into four domains: satisfaction (15 questions), impact (18 questions), social/vocational worry (7 questions) and diabetes-related worry (4 questions). The answers being arranged on a 5-point Likert scale (DCCT research group, 1988) [7]. Satisfaction domain: Very satisfied (1)– Quite satisfied (2)– Medium satisfied (3)– Somewhat satisfied (4)– Not at all satisfied (5); Impact domain: Never (1)– Almost never (2)– Sometimes (3)– Almost always (4)– Always (5); Social/vocational worry domain: Never (1)– Almost never (2)– Sometimes (3)– Almost always (4)– Always (5); diabetes-related worry domain: Never (1)– Almost never (2)– Sometimes (3)– Almost always (4)– Always (5). The total score for domain varies from 1 to 5, after adding the answers and dividing by the number of items in the domain. The higher your score, the worse the quality of life.

Statistical analysis

Data were described as mean and standard deviation (quantitative data) or as absolute numbers and percentages (qualitative data). For structural validity, confirmatory factor analysis (CFA) was performed using the RStudio software (Boston, MA, USA), using the packages lavaan and semPlot. CFA was performed with the implementation of a polychoric matrix and the robust diagonally weighted least squares (RDWLS) extraction method. The model fit was evaluated by the following indices: root mean square error of approximation (RMSEA) with 90% confidence interval (CI), comparative fit index (CFI), Tucker-Lewis Index (TLI), standardized root mean square residual (SRMR), and chi-square/degrees of freedom (DF). Values greater than 0.90 were considered adequate for CFI and TLI, and values less than 0.08 were considered adequate for RMSEA and SRMR. Values below 3.00 were considered adequate in the interpretation of the chi-square/DF [11, 12]. In CFA, factor loadings equal to or greater than 0.40 will be considered adequate for the domain.
The following indices were used to compare the DQOL models, i.e. the original version of the questionnaire [8] and the version proposed in the previous study [13]: Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC). The model with the lowest AIC and BIC values was considered the best model. For criterion validity analysis, the scores of the long (original) and short versions were correlated, with values ≥ 0.70 considered adequate [14].

Results

A total of 354 volunteers participated in the study. The majority of the sample consisted of women who were over 50 years of age, overweight, married, non-smokers, and diagnosed with type 2 DM. Additional information about the characteristics of the sample is described in Table 1.
Table 1
Characterization of the sample (n = 354)
Variables
Mean (standard deviation) or n (%)
Age (years)
51.89 (19.25)
Gender (women)
309 (87.3%)
Body mass (kg)
70.71 (9.86)
Stature (m)
1.65 (0.07)
Body mass index (kg/m²)
25.79 (3.33)
Marital status
 
 Single
110 (31.1%)
 Married
192 (54.2%)
 Divorced
37 (10.4%)
 Widower
15 (4.3%)
Smoker (yes)
38 (10.7%)
Associated comorbidities
 
Kidney disease (yes)
28 (7.9%)
Arterial hypertension (yes)
184 (52%)
Heart disease (yes)
38 (10.7%)
Type of diabetes
 
 Type 1
76 (21.5%)
 Type 2
278 (78.5%)
Short version of DQOL
 
 D1 (score, 1–5)
3.28 (0.89)
 D2 (score, 1–5)
2.69 (0.93)
 D3 (score, 1–5)
2.40 (0.80)
Long version of DQOL
 
 D1 (score, 1–5)
3.35 (0.84)
 D2 (score, 1–5)
2.89 (0.83)
 D3 (score, 1–5)
2.05 (0.97)
 D4 (score, 1–5)
2.82 (0.96)
DQOL: Diabetes Quality of Life Measure; Short version of the DQOL, D1: Satisfaction domain, D2: Impact domain, D3: Worry domain; Long version of DQOL: D1: Satisfaction domain; D2: Impact domain, D3: Social/vocational worry domain, D4: Diabetes-related worry domain
In the structural analysis (Table 2), we found that the long version of the DQOL with 4 domains and 44 items presented inadequate values for CFI and TLI. In contrast, the short version with 3 domains and 24 items showed all adequate fit indices (i.e., chi-square/GL < 3, TLI and CFI > 0.90, and RMSEA and SRMR < 0.08) and factor loadings greater than 0.40 (Fig. 1), in addition to the lowest AIC and BIC values. In addition, the short version has a valid structure and is properly correlated with the long version (rho > 0.76), meeting criterion validity (Table 3).
Table 2
Comparison between different structures of Diabetes Quality of Life Measure (DQOL).
Model
Chi-square/DF
CFI
TLI
RMSEA (90% CI)
SRMR
AIC
BIC
Model 1
2.96
0.874
0.867
0.075 (0.071, 0.078)
0.079
46497.167
46860.881
Model 2
2.81
0.941
0.934
0.072 (0.066, 0.078)
0.069
25266.707
25464.041
DF: degrees of freedom; CFI: comparative fit index; TLI: Tucker-Lewis Index; RMSEA: root mean square error of approximation; CI: confidence interval; SRMR: standardized root mean square residual; AIC: Akaike information criterion; BIC: Bayesian information criterion. Model 1: Original Brazilian structure with 4 domains and 44 items; Model 2: reduced structure with 3 domains and 24 items. Chi-square/DF < 3, TLI e CFI > 0.90, e RMSEA e SRMR < 0.08 indicate adequate adjustment of the model
Table 3
Correlation between the domains of the original and short version of the Diabetes Quality of Life Measure (DQOL).
Original version DQOL
Short version DQOL
D1
D2
D3
D1
rho = 0.966 *
-
-
D2
-
rho = 0.952 *
-
D3
-
-
rho = 0.763 *
D4
-
-
rho = 0.896 *
Short version DQOL, D1: satisfaction domain, D2: impact domain, D3: worry domain; DQOL long version: D1: satisfaction domain; D2: Impact domain, D3: social/vocational worry domain, D4: diabetes-related worry domain. * Significant correlation (p < 0.05) using Spearman correlation coefficient (rho). Adequate criterion validity (rho > 0.70)
The short version of the DQOL into Brazilian Portuguese is available at https://​questionariosbra​sil.​blogspot.​com/​.

Discussion

The present study evaluated the internal structure of the Brazilian version of the DQOL and showed that a structure of 3 domains and 24 items is adequate for assessing the quality of life. In this short version, items from domain 3 (social/vocational worry) and domain 4 (diabetes-related worry) were grouped into a single domain (worry).
The short version with 3 domains and 24 items presented in the present study was based on the internal structure of the DQOL found in the robust previous Chinese study composed of 2886 patients with diabetes, in which classical test theory (CTT) and item response theory (IRT) were used as reduction methods, each combined with exploratory factor analysis (EFA). Furthermore, the authors used CFA and Spearman correlation coefficient to validate the short version [13].
The DQOL has already been translated and validated in different countries such as Malaysia [15], China [16], Türkiye [17], Spain [18], Arabia [19], Iran [20], Pakistan [21], and Brazil [8]. However, most validations have focused on cross-cultural adaptation, internal consistency, reliability, and construct validity, but not on the structural validity of the instrument. Thus, unlike the present study, the Iranian version tested the original version of the DQOL and found adequate fit indices for the structure with 4 domains and 46 items [20]. When comparing the fit indices, the values from the Iranian study are very similar to those we found in the short version of the DQOL (RMSEA = 0.07, CFI = 0.94 and TLI = 0.93).
Regarding the use of short versions of questionnaires and scales, a previous study points out the main positive points: shorter time to complete the instrument; less possibility of unanswered items; and less possibility of filling errors or random filling of items [22]. Thus, decreasing the size of the DQOL from 44 to 24 items optimizes the response time and reduces the burden on the respondent, leading to greater adherence to the questionnaire, in addition to generating greater clarity and ease in its application.
Strengths of the present study are: (1) the adequate sample size and the analysis conducted according to COSMIN consensus; (2) the implementation of the polychoric correlation matrix when using polytomous data and extraction method of the CFA according to the categorical ordinal nature of DQOL responses. Some limitations must be considered: (1) we conducted the analysis on a sample of Brazilian patients and it is fundamental that future studies with samples from other countries test the DQOL in its version with 3 domains and 24 items; (2) in addition, other measurement properties must also be considered, such as reliability, construct validity and responsiveness.

Conclusion

The Brazilian version of the DQOL, with a structure of 3 domains and 24 items, has adequate measurement properties that support its use in clinical and scientific contexts in patients with DM type 1 and 2.

Clinical implications

The length of a questionnaire can contribute to the increase of its non-use and non-response due to the time spent and, often, the loss of interest in the proposed questions, affecting the quality and consistency of the answers. Reducing the size of the DQOL-Brazil from 44 to 24 items optimizes the response time and reduces the burden on the respondent, leading to greater adherence to the questionnaire, in addition to generating greater clarity and ease in its use.

Strenghts and limitations

Some strengths that strengthen the originality of this investigation deserve to be highlighted, such as: (1) the sample has an adequate size and the analyzes used were conducted in accordance with COSMIN; (2) when using polytomous data, we use a polychoric correlation matrix (ideal for the nature of this analysis). Honestly, we need to highlight some limitations: (1) we conducted the analysis on a sample of Brazilian patients. Therefore, it is essential that future studies with samples from other countries test the DQOL in its version with 3 domains and 24 items; (2) analysis of reliability, construct validity and responsiveness should be considered in future studies.
We used mathematical reasoning (factor analysis) to identify the best internal structure of the DQOL in Brazilian patients, but items 18 and 24 (both from the “worry” domain) do not seem to make sense for a population sample in which more than 50% of patients are married. Therefore, we suggest that further studies should examine whether these findings are replicated in unmarried patients. In addition, we advise clinicians/raters to collect patients’ marital status and analyze whether responses to these items have a significant impact on the DQOL score.

Acknowledgements

The authors thank all the interviewed patients for having agreed to participate in the research. They also thank Ceuma University and the Coordination for the Improvement of Higher Education Personnel (CAPES).

Declarations

Ethical approval

This study was approved by the Ethics Committee on Research of Ceuma University (report n. 2.853.570).
All subjects were informed of the purpose and procedures of the study, and informed consent was obtained from all the participants prior to participation.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: a scoping review. Diabetes Metab Syndr. 2020;14:1109.CrossRefPubMedPubMedCentral Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: a scoping review. Diabetes Metab Syndr. 2020;14:1109.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Yu J, Lee SH, Kim MK. Recent updates to clinical practice guidelines for diabetes Mellitus. Endocrinol Metab. 2022;37:26.CrossRef Yu J, Lee SH, Kim MK. Recent updates to clinical practice guidelines for diabetes Mellitus. Endocrinol Metab. 2022;37:26.CrossRef
5.
Zurück zum Zitat Oluchi SE, Manaf RA, Ismail S, Kadir Shahar H, Mahmud A, Udeani TK. Health Related Quality of Life measurements for diabetes: a systematic review. Int J Environ Res Public Health. 2021;18. Oluchi SE, Manaf RA, Ismail S, Kadir Shahar H, Mahmud A, Udeani TK. Health Related Quality of Life measurements for diabetes: a systematic review. Int J Environ Res Public Health. 2021;18.
6.
Zurück zum Zitat Palamenghi L, Palamenghi L, Carlucci MM, Graffigna G, Graffigna G. Measuring the Quality of Life in Diabetic Patients: A Scoping Review. J Diabetes Res. 2020;2020. Palamenghi L, Palamenghi L, Carlucci MM, Graffigna G, Graffigna G. Measuring the Quality of Life in Diabetic Patients: A Scoping Review. J Diabetes Res. 2020;2020.
7.
Zurück zum Zitat Jacobson A, Barofsky I, Cleary P, Rand L. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care. 1988;11:725–32.CrossRef Jacobson A, Barofsky I, Cleary P, Rand L. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care. 1988;11:725–32.CrossRef
8.
Zurück zum Zitat Correr CJ, Pontarolo R, Melchiors AC, Rossignoli P, Fernández-Llimós F, Radominski RB. Tradução para o português e validação do instrumento diabetes quality of life measure (DQOL-Brasil). Arq Bras Endocrinol Metabol. 2008;52:515–22.CrossRefPubMed Correr CJ, Pontarolo R, Melchiors AC, Rossignoli P, Fernández-Llimós F, Radominski RB. Tradução para o português e validação do instrumento diabetes quality of life measure (DQOL-Brasil). Arq Bras Endocrinol Metabol. 2008;52:515–22.CrossRefPubMed
9.
Zurück zum Zitat Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:1–8.CrossRef Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:1–8.CrossRef
10.
Zurück zum Zitat Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1147–57.CrossRefPubMedPubMedCentral Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1147–57.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Schermelleh-engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models. Tests of Significance and Descriptive Goodness-of-Fit Measures; 2003. Schermelleh-engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models. Tests of Significance and Descriptive Goodness-of-Fit Measures; 2003.
12.
Zurück zum Zitat Timothy A. Brown. Confirmatory Factor Analysis for Applied Research. 2nd edition. New York; 2015. Timothy A. Brown. Confirmatory Factor Analysis for Applied Research. 2nd edition. New York; 2015.
13.
Zurück zum Zitat Jin X, Liu GG, Gerstein HC, Levine MAH, Steeves K, Guan H, et al. Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL). Health Qual Life Outcomes. 2018;16:1–11.CrossRef Jin X, Liu GG, Gerstein HC, Levine MAH, Steeves K, Guan H, et al. Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL). Health Qual Life Outcomes. 2018;16:1–11.CrossRef
14.
Zurück zum Zitat Frota NT, Fidelis-de-Paula-Gomes CA, Pontes-Silva A, Pinheiro JS, de Jesus SFC, Apahaza GHS et al. 15-item Roland-Morris disability questionnaire (RMDQ-15): structural and criterion validity on patients with chronic low back pain. BMC Musculoskelet Disord. 2022;23. Frota NT, Fidelis-de-Paula-Gomes CA, Pontes-Silva A, Pinheiro JS, de Jesus SFC, Apahaza GHS et al. 15-item Roland-Morris disability questionnaire (RMDQ-15): structural and criterion validity on patients with chronic low back pain. BMC Musculoskelet Disord. 2022;23.
15.
Zurück zum Zitat Bujang MA, Ismail M, Mohd Hatta NKB, Othman SH, Baharum N, Mat Lazim SS. Validation of the malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with type 2 diabetes Mellitus. Malays J Med Sci. 2017;24:86.PubMedPubMedCentral Bujang MA, Ismail M, Mohd Hatta NKB, Othman SH, Baharum N, Mat Lazim SS. Validation of the malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with type 2 diabetes Mellitus. Malays J Med Sci. 2017;24:86.PubMedPubMedCentral
16.
Zurück zum Zitat Cheng AY, Tsui EY, Hanley AJG, Zinman B. Developing a quality of life measure for Chinese patients with diabetes. Diabetes Res Clin Pract. 1999;46:259–67.CrossRefPubMed Cheng AY, Tsui EY, Hanley AJG, Zinman B. Developing a quality of life measure for Chinese patients with diabetes. Diabetes Res Clin Pract. 1999;46:259–67.CrossRefPubMed
17.
Zurück zum Zitat Yildirim A, Akinci F, Gozu H, Sargin H, Orbay E, Sargin M. Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure. Qual Life Res. 2007;16:873–9.CrossRefPubMed Yildirim A, Akinci F, Gozu H, Sargin H, Orbay E, Sargin M. Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure. Qual Life Res. 2007;16:873–9.CrossRefPubMed
18.
Zurück zum Zitat Reviriego J, Millan MD, Millan M. Evaluation of the diabetes quality-of-life questionnaire in a Spanish population. An experience of translation and reliability. PharmacoEconomics. 1996;10:614–22.CrossRefPubMed Reviriego J, Millan MD, Millan M. Evaluation of the diabetes quality-of-life questionnaire in a Spanish population. An experience of translation and reliability. PharmacoEconomics. 1996;10:614–22.CrossRefPubMed
19.
Zurück zum Zitat Al-Qerem W, Al-Maayah B, Ling J. Developing and validating the arabic version of the diabetes quality of life questionnaire. East Mediterr Health J. 2021;27:414–26.CrossRefPubMed Al-Qerem W, Al-Maayah B, Ling J. Developing and validating the arabic version of the diabetes quality of life questionnaire. East Mediterr Health J. 2021;27:414–26.CrossRefPubMed
20.
Zurück zum Zitat Pakpour AH, Saffari M, Burri A. Translation and validation of an Iranian version of the diabetes quality of Life measure. J Diabetes Investig. 2012;3:471–8.CrossRefPubMedPubMedCentral Pakpour AH, Saffari M, Burri A. Translation and validation of an Iranian version of the diabetes quality of Life measure. J Diabetes Investig. 2012;3:471–8.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Haider S, Saleem F, Ahmad N, Iqbal Q, Bashaar M. Translation, validation, and psychometric evaluation of the diabetes quality-of-life brief clinical inventory: the Urdu Version. J Multidiscip Healthc. 2022;15:955.CrossRefPubMedPubMedCentral Haider S, Saleem F, Ahmad N, Iqbal Q, Bashaar M. Translation, validation, and psychometric evaluation of the diabetes quality-of-life brief clinical inventory: the Urdu Version. J Multidiscip Healthc. 2022;15:955.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Fidelis-de-Paula-Gomes CA, Guimarães-Almeida MQ, Pontes-Silva A, Protázio JB, Apahaza GHS, Souza C da. Ten-item Lower Extremity Functional Scale (LEFS-10): instrument reduction based on Brazilian patients with lower limb dysfunction. Arch Phys Med Rehabil. 2023;104:438–43.CrossRefPubMed Fidelis-de-Paula-Gomes CA, Guimarães-Almeida MQ, Pontes-Silva A, Protázio JB, Apahaza GHS, Souza C da. Ten-item Lower Extremity Functional Scale (LEFS-10): instrument reduction based on Brazilian patients with lower limb dysfunction. Arch Phys Med Rehabil. 2023;104:438–43.CrossRefPubMed
Metadaten
Titel
The best internal structure of the Diabetes Quality of Life Measure (DQOL) in Brazilian patients
verfasst von
Denilson Menezes Almeida
Aldair Darlan Santos-de-Araújo
José Mário Costa Brito Júnior
Marcela Cacere
André Pontes-Silva
Cyrene Piazera Costa
Maria Cláudia Gonçalves
José Márcio Soares Leite
Almir Vieira Dibai-Filho
Daniela Bassi-Dibai
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2024
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18090-z

Weitere Artikel der Ausgabe 1/2024

BMC Public Health 1/2024 Zur Ausgabe